DRAP

A new federal body will take over medicine pricing from DRAP, aligning with ongoing health sector reforms.

Federal cabinet’s move compelled by ‘rising rates of raw material in global market’

Skin treatments can only be performed by qualified professionals but there does not seem to be any check and balance

Drugs authority seizes toxic propylene glycol, linked to child deaths; recall issued, investigation underway

Say policies of regulatory body are not public friendly

Initiates regular enquiry into assets of Sheikh Akhtar Hussain

Sheikh Hussain is accused of holding fake PhD degree

Proposal to increase prices of 262 medicines prompts call for review of drug pricing methodology

Organization says DRAP found other products were also contaminated and issued a recall in Nov

Executive director says grey market has become bigger than white market